Wagner Wealth Management, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Wagner Wealth Management, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2022$2,0000.0%280.0%0.00%
-50.0%
Q2 2022$2,000
+100.0%
280.0%0.00%
+100.0%
Q4 2021$1,000
-50.0%
280.0%0.00%
-50.0%
Q3 2021$2,0000.0%280.0%0.00%
+100.0%
Q2 2021$2,000
-33.3%
280.0%0.00%
-50.0%
Q1 2021$3,000
-80.0%
28
-78.6%
0.00%
-80.0%
Q3 2018$15,000
+25.0%
1310.0%0.01%
+11.1%
Q2 2018$12,000
+20.0%
1310.0%0.01%
+12.5%
Q1 2018$10,0000.0%131
+27.2%
0.01%
+14.3%
Q4 2017$10,0001030.01%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders